Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Mattsson

Showing results (91-100 of 395) with videos related to

Pageof 40
Sort By:
Drug and Alcohol Dependence|July 20, 2014
History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stressTimothy C Durazzo, Niklas Mattsson, Michael W Weiner, et al.
BMC Neurology|January 9, 2013
Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infectionDaniel Bremell, Niklas Mattsson, Mikael Edsbagge, et al.
Biomarkers in Medicine|August 25, 2012
Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challengesJonathan W Bartlett, Chris Frost, Niklas Mattsson, et al.
Neuroscience Letters|January 18, 2007
Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patientsNiklas Mattsson, Sara Haghighi, Oluf Andersen, et al.
Neurochemistry International|December 20, 2015
Total-tau and neurofilament light in CSF reflect spinal cord ischaemia after endovascular aortic repairEdyta Merisson, Niklas Mattsson, Henrik Zetterberg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 15, 2019
Cerebrospinal fluid levels of neurogranin in Parkinsonian disordersSara Hall, Shorena Janelidze, Henrik Zetterberg, et al.
Clinical Biochemistry|November 27, 2013
Automated cerebrospinal fluid cell count--new reference ranges and evaluation of its clinical use in central nervous system infectionsDaniel Bremell, Niklas Mattsson, Fredrik Wallin, et al.
EMBO Molecular Medicine|August 19, 2016
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's diseaseNiklas Mattsson, Philip S Insel, Sebastian Palmqvist, et al.
Neurology|May 14, 2020
The implications of different approaches to define AT(N) in Alzheimer diseaseNiklas Mattsson-Carlgren, Antoine Leuzy, Shorena Janelidze, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 27, 2018
Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithmsSebastian Palmqvist, Philip S Insel, Henrik Zetterberg, et al.
Pageof 40

Showing results (91-100 of 395) with videos related to

Sort By:
Pageof 40
Drug and Alcohol Dependence|July 20, 2014
History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stressTimothy C Durazzo, Niklas Mattsson, Michael W Weiner, et al.
BMC Neurology|January 9, 2013
Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infectionDaniel Bremell, Niklas Mattsson, Mikael Edsbagge, et al.
Biomarkers in Medicine|August 25, 2012
Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challengesJonathan W Bartlett, Chris Frost, Niklas Mattsson, et al.
Neuroscience Letters|January 18, 2007
Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patientsNiklas Mattsson, Sara Haghighi, Oluf Andersen, et al.
Neurochemistry International|December 20, 2015
Total-tau and neurofilament light in CSF reflect spinal cord ischaemia after endovascular aortic repairEdyta Merisson, Niklas Mattsson, Henrik Zetterberg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 15, 2019
Cerebrospinal fluid levels of neurogranin in Parkinsonian disordersSara Hall, Shorena Janelidze, Henrik Zetterberg, et al.
Clinical Biochemistry|November 27, 2013
Automated cerebrospinal fluid cell count--new reference ranges and evaluation of its clinical use in central nervous system infectionsDaniel Bremell, Niklas Mattsson, Fredrik Wallin, et al.
EMBO Molecular Medicine|August 19, 2016
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's diseaseNiklas Mattsson, Philip S Insel, Sebastian Palmqvist, et al.
Neurology|May 14, 2020
The implications of different approaches to define AT(N) in Alzheimer diseaseNiklas Mattsson-Carlgren, Antoine Leuzy, Shorena Janelidze, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 27, 2018
Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithmsSebastian Palmqvist, Philip S Insel, Henrik Zetterberg, et al.
Pageof 40